Abstract:OBJECTIVE:To investigate the characteristic of dynamic glucose level in obstructive sleep apnea-hypopnea syndrome (OSAHS) patients with newly diagnosed type 2 diabetes mellitus (T2DM) and to evaluate the effect of continuous positive airway pressure (CPAP) treatment on the glucose level.METHODS:A total of 65 cases of patients with T2DM who were newly diagnosed by oral glucose tolerance test (OGTT) were enrolled from April 2014 to April 2015 in Gansu Provincial Hospital, and divided into simple T2DM group (n=30) and OSAHS with T2DM group (n=35) according to aponea-hypopnea index (AHI) which was monitored by polysomnography (PSG). Their general clinical data were collected, and glucose level of different periods was monitored by continuous glucose moitoring system (CGMS). Changes of glucose level were compared between two groups before and after CPAP treatment.RESULTS:Age, gender proportion, BMI, smoking and drinking history, glycosylated hemoglobin (HbA1c) and blood lipid profile had no significantly difference between two groups. Longer neck circumstance and higher waist-hip ration (WHR), higher systolic blood pressure and diastolic blood pressure, higher fasting plasma glucose (FPG) [(9.4 ± 3.2) vs (7.3 ± 2.1) mmol/L, P=0.028] and fasting insulin (FINS) [(19.2 ± 8.7) vs (11.1 ± 4.7) mU/L, P=0.044] level, more serious homeostasis model assessment insulin resistance (HOMA-IR) were found in OSAHS patients with T2DM when compared to patients in simple T2DM group. The average dynamic glucose level of 24 hours, daytime, nocturnal and sleep time in OSAHS with T2DM group were higher than that in the simple T2DM group (all P<0.05). The alarming times when the average dynamic glucose level of nocturnal time was more than 0.1 mmol·L⁻¹·min⁻¹ in T2DM with OSAHS was more than that in control group (P=0.001). After treatment of CPAP, the level of AHI [(5.9 ± 3.6) vs (56.7 ± 11.4) times/h, P<0.001], average dynamic glucose level of 24 hours, day, nocturnal and sleep time were obviously decreased (all P<0.05); lowest saturation oxygen (LSpO₂) was significantly increased [(92.3 ± 3.7)% vs (81.5 ± 20.2)%, P<0.001]; the alarming times and HOMA-IR were obviously decreased (P=0.019, 0.043). According to multiple linear regression analysis, the AHI (β=0.736, P<0.001) in OSAHS with T2DM group was positively related to the average dynamic glucose level during sleep time, but the LSpO₂(β=-0.889, P<0.001) was negatively correlated.CONCLUSIONS:OSAHS patients with newly diagnosed T2DM have higher glucose level than that in simple T2DM patients, and CPAP therapy can obviously decrease the glucose level in newly diagnosed T2DM patients with OSAHS. AHI and LSpO₂may influence the average dynamic glucose level during sleep time.

0884 Slow Wave Sleep Is Associated with Glucose Metabolism in Obstructive Sleep Apnea: A Registry-based Study

0837 Total Sleep Time and the Severity of Apnea-hypopnea Index Are Associated with Glucose Metabolism in Patients with Osa and Prediabetes

Obstructive Sleep Apnea is Associated with Impaired Glucose Metabolism in Han Chinese Subjects.

[Factors Influencing Glucose Metabolism in Young Obese Subjects with Obstructive Sleep Apnea Hypopnea Syndrome].

Dynamic changes in nocturnal blood glucose levels are associated with sleep-related features in patients with obstructive sleep apnea

Independent Relationships Between Cardinal Features of Obstructive Sleep Apnea and Glycometabolism: a Cross-Sectional Study.

Clinical Observation of Glucose Metabolism Disorders in Elderly Patients with Obstructive Sleep Apnea Disorder

Effect of Interaction Between Slow Wave Sleep and Obstructive Sleep Apnea on Insulin Resistance: A Large-Scale Study

Paired Study on Glucose Metabolism in Obstructive Sleep Apnea Syndrome Patients with Normal Glucose Tolerance

Associations between common sleep disturbances and cardiovascular risk in patients with obstructive sleep apnea: A large-scale cross-sectional study

0565 Obstructive Sleep Apnea, but Not Short Sleep Duration, is Independently Associated with Insulin Resistance: A Large-Scale Cohort Study

Elevated low-density lipoprotein cholesterol is independently associated with obstructive sleep apnea: evidence from a large-scale cross-sectional study

0882 The Association Between Objective Daytime Sleepiness and Glucose Metabolism in OSA Patients: A Metabolomics Study

The association of objective daytime sleepiness with impaired glucose metabolism in patients with obstructive sleep apnea: a multi-omics study

Nocturnal Hypoxemia Causes Hyperglycemia in Patients with Obstructive Sleep Apnea and Type 2 Diabetes Mellitus.

Independent relationship between sleep apnea-specific hypoxic burden and glucolipid metabolism disorder: a cross-sectional study

Contribution of Obstructive Sleep Apnea Syndrome to the Development of Abnormal of Glucose Metabolism

Interaction between obstructive sleep apnea and short sleep duration on insulin resistance: a large-scale study

The use of the sleep apnea-specific hypoxic burden to predict obstructive sleep apnea hypopnea syndrome: Evidence from a large cross-sectional study

[Effect of CPAP Therapy on Dynamic Glucose Level in OSAHS Patients with Newly Diagnosed T2DM].